Overall survival with nivolumab (NIVO) and ipilimumab (IPI) combination therapy in a phase III trial of advanced melanoma (CHECKMATE 067) Meeting Abstract
| Authors: | Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Schadendorf, D.; Ferrucci, P. F.; Smylie, M.; Dummer, R.; Hill, A.; Haanen, J.; Maio, M.; McArthur, G.; Walker, D.; Rollin, L.; Horak, C.; Hodi, F. S.; Wolchok, J. D. |
| Abstract Title: | Overall survival with nivolumab (NIVO) and ipilimumab (IPI) combination therapy in a phase III trial of advanced melanoma (CHECKMATE 067) |
| Meeting Title: | 2017 Annual Scientific Meeting of the Medical Oncology Group of Australia Incorporated (MOGA) |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 13 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2017 Aug 2-4 |
| Meeting Location: | Melbourne, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2017-08-01 |
| Start Page: | 48 |
| Language: | English |
| ACCESSION: | WOS:000427542700011 |
| PROVIDER: | wos |
| DOI: | 10.1111/ajco.12726 |
| PUBMED: | 28719116 |
| Notes: | Meeting Abstract -- Source: Wos |
